Visual outcomes, safety profile and morphometric response of optical coherence tomography biomarkers to ranibizumab biosimilar treatment in neovascular age-related macular degeneration: Real-world evidence

Visual outcomes, safety profile and morphometric response of optical coherence tomography biomarkers to ranibizumab biosimilar treatment in neovascular age-related macular degeneration: Real-world evidence

Purpose: The aim of this study was to evaluate the safety, efficacy, and morphological response of intravitreal ranibizumab biosimilar (Razumab) in neovascular age-related macular degeneration (n-AMD) up to 12 weeks. Methods: Retrospective analysis of 20 eyes of n-AMD receiving 4 weekly intravitreal...

Full description

Bibliographic Details
Main Authors: Aditya S Kelkar, Jai Kelkar, Mounika Bolisetty, Shreekant B Kelkar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Ophthalmology
Subjects:
age-related macular degeneration
anti-vegf
biosimilars
optical coherence tomography
razumab
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=6;spage=1469;epage=1474;aulast=Kelkar

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=6;spage=1469;epage=1474;aulast=Kelkar

Similar Items